Sympathetic ophthalmia following vitrectomy for endophthalmitis after intravitreal bevacizumab.
OBJECTIVE
To describe a case of sympathetic ophthalmia following vitrectomy for endophthalmitis after an intravitreal injection of bevacizumab.


METHODS
Retrospective case report.


METHODS
An 84-year-old male developed sympathetic ophthalmia 4 months after vitrectomy for endophthalmitis following an intravitreal injection. The inciting blind eye was enucleated.


RESULTS
Histopathology demonstrated sympathetic ophthalmia and phacoanaphylactic endophthalmitis. Visual acuity improved from 20/200 to 20/30 in the sympathizing eye with a combination of oral prednisone and azathioprine.


CONCLUSIONS
Sympathetic ophthalmia can develop following exogenous endophthalmitis but has a good visual prognosis with appropriate treatment.
Sisk
Robert A
RA
Bascom Palmer Eye Institute, Miller School of Medicine, University of Miami, Miami, Florida 33136, USA. rsisk@med.miami.edu
Davis
Janet L
JL
Dubovy
Sander R
SR
Smiddy
William E
WE
D000284:Administration, Oral; D000369:Aged, 80 and over; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D001379:Azathioprine / Q000008:administration & dosage; D000068258:Bevacizumab; D004359:Drug Therapy, Combination; D009877:Endophthalmitis / Q000601:surgery*; D015353:Eye Enucleation; D006801:Humans; D007267:Injections; D008297:Male; D009879:Ophthalmia, Sympathetic / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology / Q000601:surgery; D011183:Postoperative Complications; D011241:Prednisone / Q000008:administration & dosage; D012189:Retrospective Studies; D014792:Visual Acuity; D014821:Vitrectomy; D014822:Vitreous Body
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D001379:Azathioprine; D011241:Prednisone